KALV
KalVista Pharmaceuticals, Inc.Healthcare$19.90
▲ Bullish
Mkt Cap: $1.02B|Float: 27.9M|SI: 69.6%|DTC: 23.1
Data as of market close Apr 2, 2026
IV Rank
43
IV Pctl
22%
HV 20d
66.8%
52W Range
$9-$21
ATR(14)
$1.23
Exp. Move
±19.1%
P/C Ratio
0.53
Earnings
May 5
GEX Positive
DEX Long
Net Call Premium
IV Moderate
Max Pain Below
Exp. Move Wide
Low Put/Call
KALV Key Options Data
- IV Rank
- 42.8%
- Total GEX
- $0.00B
- Total DEX
- $1.2M
- Max Pain
- $17.50
- Expected Move
- ±19.1%
- Put/Call OI
- 0.53
- Net Premium
- $2.9M
- Spot Price
- $19.90
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$3.80 | ±19.1% | $16.10 | $23.70 |
| 2026-05-15 | 43 | ±$2.35 | ±11.8% | $17.55 | $22.25 |
| 2026-06-18 | 77 | ±$1.90 | ±9.6% | $18.00 | $21.80 |
| 2026-09-18 | 169 | ±$5.85 | ±29.4% | $14.05 | $25.75 |
| 2026-12-18 | 260 | ±$5.75 | ±28.9% | $14.15 | $25.65 |
Explore KALV options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.